GEARX — GMO International Equity Allocation Series Fund
Data updated: 2021-01-29
GEARX — GMO International Equity Allocation Series Fund. Money Market · $11.36M AUM · 0.71% expense ratio. Holdings, fees, performance and SEC filings.
GEARX Fund Overview
GEARX — GMO International Equity Allocation Series Fund is a US mutual fund managed by GMO Series Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: GMO Series Trust
- Category: Money Market
- Assets under management: $11.36M
- 1-year return: 6.5%
- Ticker: GEARX
- SEC CIK: 0001521894
- SEC series ID: S000035215
- Share class ID: C000108335
GEARX Investment Objective and Strategy
GMO International Equity Allocation Series Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by GMO Series Trust.
Investment objective
Total return greater than that of its benchmark, the MSCI ACWI ex USA.
Principal investment strategy
"The Fund invests substantially all of its assets in Class III shares of GMO International Equity Allocation Fund (""IEAF""), a series of GMO Trust not offered in this Prospectus. IEAF invests primarily in shares of other funds managed by GMO (""GMO Funds""). The Fund's investment objective and principal investment strategies are substantially similar to those of IEAF. Except as otherwise indicated, references to the Fund may also refer to IEAF, and references to actions undertaken or investments held by the Fund may also refer to those by IEAF. GMO serves as investment adviser for both the Fund and IEAF. The Fund is a fund of funds and invests primarily in equities traded in non-U.S. markets (including emerging markets) through shares of GMO Funds that invest in equities (collectively, the ""GMO Equity Funds""), GMO Alpha Only Fund and GMO Risk Premium Fund (collectively, the ""underlying GMO Funds"").
The Fund also may invest directly in securities (including other underlying funds) and derivatives. GMO uses its multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to determine the Fund's allocations to particular underlying GMO Funds. An important component of those forecasts is GMO's expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value. GMO changes the Fund's holdings of the underlying GMO Funds in response to changes in GMO's investment outlook and market valuations and may use redemptions or purchases of Fund shares to rebalance the Fund's investments. The factors GMO considers and investment methods GMO uses can change over time. Under normal circumstances, the Fund invests (including through investment in the underlying GMO Funds) at least 80% of its assets in equities.
The term ""equities"" refers to direct and indirect (e.g., through the underlying GMO Funds) investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. The Fund may invest in securities of companies of any market capitalization. In addition, the Fund may lend its portfolio securities. The Fund also may invest in GMO U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. The Fund may hold cash, cash equivalents, and/or U.S. government securities to manage cash inflows and outflows as a result of shareholder purchases and redemptions."
GEARX Performance
Total returns for GEARX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 6.5% |
GEARX Risk Information
Risk metrics for GEARX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 25.0%
GEARX Costs and Fees
GEARX costs about $71 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.71%
- Gross expense ratio: 0.71%
- Portfolio turnover: 2%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
GEARX Cashflows
Over the 12 months to 2020-11, GMO International Equity Allocation Series Fund had net inflows of $334.10K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2020-11 | −$213.78K |
| 2020-10 | −$226.65K |
| 2020-09 | −$209.93K |
| 2020-08 | $295.00K |
| 2020-07 | $130.33K |
| 2020-06 | $199.66K |
GEARX Debt Constituents
No individual debt constituents are reported in GMO International Equity Allocation Series Fund's latest SEC N-PORT filing.
GEARX Prospectus and SEC Filings
Official GMO International Equity Allocation Series Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2020-07-17
- Prospectus (485BPOS) — filed 2019-07-22
- Prospectus (485BPOS) — filed 2018-07-23
- Portfolio holdings (N-PORT) — filed 2021-01-29
- Portfolio holdings (N-PORT) — filed 2020-10-28
- Portfolio holdings (N-PORT) — filed 2020-07-28
- Annual census (N-CEN) — filed 2020-05-12
- Annual census (N-CEN) — filed 2019-05-10
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.